Study of prostate-specific antigen levels during salvage radiotherapy after prostate cancer surgery

Abstract Background Administration of adjuvant or salvage radiotherapy (RT) after prostate cancer (PCa) surgery is supported by clinical evidence and is a widely adopted strategy. On occasion, we detect changes in prostate-specific antigen (PSA) levels, such as a transient elevation or decline, duri...

Full description

Bibliographic Details
Main Authors: Takuya Aizawa, Toshiya Maebayashi, Naoya Ishibashi, Masakuni Sakaguchi, Akahiko Sato, Kenya Yamaguchi
Format: Article
Language:English
Published: BMC 2023-10-01
Series:BMC Urology
Subjects:
Online Access:https://doi.org/10.1186/s12894-023-01323-5
_version_ 1797451359029559296
author Takuya Aizawa
Toshiya Maebayashi
Naoya Ishibashi
Masakuni Sakaguchi
Akahiko Sato
Kenya Yamaguchi
author_facet Takuya Aizawa
Toshiya Maebayashi
Naoya Ishibashi
Masakuni Sakaguchi
Akahiko Sato
Kenya Yamaguchi
author_sort Takuya Aizawa
collection DOAJ
description Abstract Background Administration of adjuvant or salvage radiotherapy (RT) after prostate cancer (PCa) surgery is supported by clinical evidence and is a widely adopted strategy. On occasion, we detect changes in prostate-specific antigen (PSA) levels, such as a transient elevation or decline, during RT. Thus, we retrospectively investigated the frequency of changes in PSA levels, their associations with histopathological parameters, PSA doubling time (PSADT), and biochemical recurrence (BR) of PCa. Methods This study included 23 consecutive patients who underwent surgery for PCa between 2012 and 2019, received salvage RT without hormone therapy, and exhibited changes in PSA levels during RT. The prostatic bed was irradiated with a total dose of 64 to 66 Gy. BR was defined as consecutive PSA levels exceeding 0.2 ng/mL or having to start hormone therapy because of PSA elevation after salvage RT. Results During salvage RT after PCa surgery, PSA levels transiently increased in 11 patients (47.8%) and decreased in 12 (52.2%). When factors associated with BR were examined in patients with transient PSA elevation, seminal vesicle invasion and preoperative PSA values were identified as being statistically significant. When factors for BR were examined in patients with a decline in PSA levels, the Gleason score and PSADT were identified as being significant. Among the cases of a decline in PSA levels during salvage RT, those who received a radiation dose of less than 36 Gy did not experience BR. Similarly, patients who exhibited changes in PSA levels during salvage RT and did not have perineural invasion did not experience BR. Conclusion This is the first study to examine the histopathological factors possibly affecting BR in patients undergoing salvage RT after PCa surgery. The results indicate that in patients with transient PSA elevation, seminal vesicle invasion is a significant risk factor. On the other hand, in patients with a decline in PSA levels during irradiation, the Gleason score and perineural invasion were found to be potential risk factors for BR. These findings suggest that a thorough examination of postoperative histopathological results may be necessary for the optimal management of patients with PCa.
first_indexed 2024-03-09T14:53:32Z
format Article
id doaj.art-bbd380ef536141938cfe565d91a72b71
institution Directory Open Access Journal
issn 1471-2490
language English
last_indexed 2024-03-09T14:53:32Z
publishDate 2023-10-01
publisher BMC
record_format Article
series BMC Urology
spelling doaj.art-bbd380ef536141938cfe565d91a72b712023-11-26T14:20:51ZengBMCBMC Urology1471-24902023-10-012311810.1186/s12894-023-01323-5Study of prostate-specific antigen levels during salvage radiotherapy after prostate cancer surgeryTakuya Aizawa0Toshiya Maebayashi1Naoya Ishibashi2Masakuni Sakaguchi3Akahiko Sato4Kenya Yamaguchi5Department of Radiology, Nihon University School of MedicineDepartment of Radiology, Nihon University School of MedicineDepartment of Radiology, Nihon University HospitalDepartment of Radiology, Nihon University School of MedicineDepartment of Radiology, Nihon University School of MedicineDepartment of Urology, Nihon University HospitalAbstract Background Administration of adjuvant or salvage radiotherapy (RT) after prostate cancer (PCa) surgery is supported by clinical evidence and is a widely adopted strategy. On occasion, we detect changes in prostate-specific antigen (PSA) levels, such as a transient elevation or decline, during RT. Thus, we retrospectively investigated the frequency of changes in PSA levels, their associations with histopathological parameters, PSA doubling time (PSADT), and biochemical recurrence (BR) of PCa. Methods This study included 23 consecutive patients who underwent surgery for PCa between 2012 and 2019, received salvage RT without hormone therapy, and exhibited changes in PSA levels during RT. The prostatic bed was irradiated with a total dose of 64 to 66 Gy. BR was defined as consecutive PSA levels exceeding 0.2 ng/mL or having to start hormone therapy because of PSA elevation after salvage RT. Results During salvage RT after PCa surgery, PSA levels transiently increased in 11 patients (47.8%) and decreased in 12 (52.2%). When factors associated with BR were examined in patients with transient PSA elevation, seminal vesicle invasion and preoperative PSA values were identified as being statistically significant. When factors for BR were examined in patients with a decline in PSA levels, the Gleason score and PSADT were identified as being significant. Among the cases of a decline in PSA levels during salvage RT, those who received a radiation dose of less than 36 Gy did not experience BR. Similarly, patients who exhibited changes in PSA levels during salvage RT and did not have perineural invasion did not experience BR. Conclusion This is the first study to examine the histopathological factors possibly affecting BR in patients undergoing salvage RT after PCa surgery. The results indicate that in patients with transient PSA elevation, seminal vesicle invasion is a significant risk factor. On the other hand, in patients with a decline in PSA levels during irradiation, the Gleason score and perineural invasion were found to be potential risk factors for BR. These findings suggest that a thorough examination of postoperative histopathological results may be necessary for the optimal management of patients with PCa.https://doi.org/10.1186/s12894-023-01323-5PSAPSADTProstate cancerRadiotherapyBiochemical recurrence
spellingShingle Takuya Aizawa
Toshiya Maebayashi
Naoya Ishibashi
Masakuni Sakaguchi
Akahiko Sato
Kenya Yamaguchi
Study of prostate-specific antigen levels during salvage radiotherapy after prostate cancer surgery
BMC Urology
PSA
PSADT
Prostate cancer
Radiotherapy
Biochemical recurrence
title Study of prostate-specific antigen levels during salvage radiotherapy after prostate cancer surgery
title_full Study of prostate-specific antigen levels during salvage radiotherapy after prostate cancer surgery
title_fullStr Study of prostate-specific antigen levels during salvage radiotherapy after prostate cancer surgery
title_full_unstemmed Study of prostate-specific antigen levels during salvage radiotherapy after prostate cancer surgery
title_short Study of prostate-specific antigen levels during salvage radiotherapy after prostate cancer surgery
title_sort study of prostate specific antigen levels during salvage radiotherapy after prostate cancer surgery
topic PSA
PSADT
Prostate cancer
Radiotherapy
Biochemical recurrence
url https://doi.org/10.1186/s12894-023-01323-5
work_keys_str_mv AT takuyaaizawa studyofprostatespecificantigenlevelsduringsalvageradiotherapyafterprostatecancersurgery
AT toshiyamaebayashi studyofprostatespecificantigenlevelsduringsalvageradiotherapyafterprostatecancersurgery
AT naoyaishibashi studyofprostatespecificantigenlevelsduringsalvageradiotherapyafterprostatecancersurgery
AT masakunisakaguchi studyofprostatespecificantigenlevelsduringsalvageradiotherapyafterprostatecancersurgery
AT akahikosato studyofprostatespecificantigenlevelsduringsalvageradiotherapyafterprostatecancersurgery
AT kenyayamaguchi studyofprostatespecificantigenlevelsduringsalvageradiotherapyafterprostatecancersurgery